A ~ 4% deficit in stride length was observed in the old WT when compared to the middle-aged WT indicating the presence of FGF2 can maintain healthy muscle strength relative to the Fgf2KO. As previously reported, in an otherwise healthy patient with neuromuscular disease, a ~ 10% reduction in stride length could be clinically relevant23. Here, FGF2 is linked to neuromuscular disease.